The angiotensin receptor antagonist valsartan does not mitigate diabetes-associated bladder enlargement in rats
Introduction: An enlargement of the urinary bladder occurs in all models of type 1 and many of type 2 diabetes (T2DM), but the underlying mechanisms are largely unknown. As angiotensin receptor antagonists are anti-hypertrophic in many tissues, we explored whether valsartan can attenuate bladder enlargement [for full text, please go to the a.m. URL]
Institutions
- Ankara University (TR)
- Johannes Gutenberg University Mainz (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3205/24dkg04
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00